Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence.
about
N. meningitidis and TLR Polymorphisms: A Fascinating Immunomodulatory NetworkThe Group A Streptococcal Carrier State Reviewed: Still an EnigmaClinical and laboratory evidence for Neisseria meningitidis biofilms.Whole genome sequencing reveals within-host genetic changes in paired meningococcal carriage isolates from Ethiopia.Update on meningococcal disease with emphasis on pathogenesis and clinical managementComparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage.Importance of complement source in measuring meningococcal bactericidal titers.Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.Failure of chemoprophylaxis to prevent meningococcal disease.Early appearance of bactericidal antibodies after polysaccharide challenge of toddlers primed with a group C meningococcal conjugate vaccine: what is its role in the maintenance of protection?Measurement of antibodies against meningococcal capsular polysaccharides B and C in enzyme-linked immunosorbent assays: towards an improved surveillance of meningococcal disease.Meningococcal infections in the Hamilton area during 1978.Early treatment with parenteral penicillin in meningococcal disease.Carriage of Neisseria species in communities with different rates of meningococcal disease.Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections.Global epidemiology of meningococcal disease.Lessons from meningococcal carriage studies.The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine.Emergence of a virulent clone of Neisseria meningitidis serotype 2a that is associated with meningococcal group C disease in Canada.Distribution of serogroups and genotypes among disease-associated and carried isolates of Neisseria meningitidis from the Czech Republic, Greece, and NorwayAntibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents.Waning Immunity and Microbial Vaccines-Workshop of the National Institute of Allergy and Infectious Diseases.Modelling meningococcal meningitis in the African meningitis belt.Prevalence of Neisseria meningitidis Carriage with Identification of Serogroups and Genogroups in Professional Soldiers.Biologic function of the serum IgA system: modulation of complement-mediated effector mechanisms and conservation of antigenic mass.Meningococci.Predicting meningococcal disease outbreaks in structured populations.A cluster of invasive meningococcal disease (IMD) caused by Neisseria meningitidis serogroup W among university students, France, February to May 2017.Epidemiology of Neisseria meningitidis; prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease.Factor H-binding protein is important for meningococcal survival in human whole blood and serum and in the presence of the antimicrobial peptide LL-37.Polysaccharide-protein conjugate vaccination induces antibody production but not sustained B-cell memory in the human nasopharyngeal mucosa.Meningococcal disease: the organism, clinical presentation, and worldwide epidemiology.Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine.The ongoing challenge of meningococcal disease.Declining incidence of meningococcal disease in Denmark, confirmed by a capture-recapture analysis for 1994 and 2002.Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica.Comparative studies on pharyngeal carriage of Neisseria meningitidis during a localized outbreak of serogroup C meningococcal disease.The natural history of meningococcal carriage and disease
P2860
Q26744800-EA6CA973-C7EC-4959-882A-CF73C0B29612Q26775604-A721A074-E2E0-4CBE-9EBE-A27EFD46649EQ33685515-95B54A34-463F-414E-A428-48B0B9AF6499Q33730806-5A774B17-1FD3-4FAA-9BF3-A6D5BA7DBEF5Q33812435-181E239D-4A12-4FA3-8B5D-D6AE6D429D93Q33972994-A9902ADD-83CB-4614-A7AD-18F12E25381CQ33999159-69601276-9FDF-4113-99E8-23637B863583Q34006352-95959BE5-FE53-4D4D-8D11-F6CBD559F409Q34285182-F8E9416E-C9F0-483D-AF1C-BEE3727D09D2Q34975007-563027AF-E847-4CEF-AF53-2A5B034ED612Q35229690-C04C8E80-238E-4E2C-A880-4255DB9F21F4Q35645414-B32DD91D-E9B9-48E2-8B8E-08964E7FCB5EQ35781412-459AF0D4-38B6-4829-9245-978182568CD5Q35893225-C5D874EB-9D4B-4DDF-BC3C-AEF69275CD8EQ36434366-895DC19B-24AD-4347-BDBD-CE46957ED55AQ36634411-71EB27D2-1848-4770-B270-954249E7FF34Q36711465-2D6CFB2D-8FB9-455C-BBF9-D87E89E6E5A4Q37037419-3D637FF7-F033-4050-9BCF-0C740AE13310Q37058833-7DFA969C-D8A7-45B8-AE33-EDE9CBFBEBA1Q37130274-FD9C2DA4-7152-4668-ACE7-2A5A90A78B20Q37244869-C30AA921-0EDF-4E02-BC55-333C9BEDE2FDQ37597599-69FE0ECF-3858-497E-A82B-C8E4EDBC386FQ37713775-1F5976E6-280F-406C-BBEC-C294858624D0Q38685505-31D435EF-86AD-4D52-B8FC-66C5E5A35F94Q39095253-02D6E689-5A85-4758-9EC6-15D0DCEB2C5CQ39145756-82BA8C9C-101D-4605-BC9F-0E09D6C21021Q40152772-B494E3BF-6BDB-472E-A7DB-F569BDC8D738Q40259735-929DAB91-1068-4464-A9EF-8AD173055E66Q40524279-34F71DD7-F629-4F12-A3B4-6221E5977AE1Q41271773-86E694D8-4343-4219-80C1-D4AD86DA681CQ41601333-E184CF22-018F-4E46-8918-17C9C70CBAEAQ41825787-B14D36E6-E38C-4B8D-931F-63267D63E0ECQ43876810-9648D63C-7171-40A1-8CDC-DE69F037DD31Q44495758-A1F62DB7-1F8A-4C2F-8F92-EDC2E9C61BBCQ45340766-491E6B51-57DA-499B-B7F1-913A4AA1F94AQ49344090-A7E0308D-9810-401C-BE12-72358B7131FAQ50546191-9B374C7A-EC00-4281-807B-E2DCD7A6EF0FQ52080156-087D3CF6-4494-422D-ABF5-CD93D6A0B53EQ54252793-6FB3E899-991D-4F47-B7E2-F147F8BEF61DQ58668846-66F22BF9-066E-441A-A831-747DCAF5FFF3
P2860
Immunological investigations of meningococcal disease. III. Brevity of group C acquisition prior to disease occurrence.
description
1977 nî lūn-bûn
@nan
1977年の論文
@ja
1977年学术文章
@wuu
1977年学术文章
@zh-cn
1977年学术文章
@zh-hans
1977年学术文章
@zh-my
1977年学术文章
@zh-sg
1977年學術文章
@yue
1977年學術文章
@zh
1977年學術文章
@zh-hant
name
Immunological investigations o ...... n prior to disease occurrence.
@en
type
label
Immunological investigations o ...... n prior to disease occurrence.
@en
prefLabel
Immunological investigations o ...... n prior to disease occurrence.
@en
P2093
P2860
P1476
Immunological investigations o ...... n prior to disease occurrence.
@en
P2093
P2860
P304
P356
10.3109/INF.1977.9.ISSUE-2.09
P577
1977-01-01T00:00:00Z